Results 281 to 290 of about 4,841,252 (345)
Some of the next articles are maybe not open access.
High-dose cisplatin-related peripheral neuropathy
Cancer Nursing, 1988Until recently, peripheral neuropathy (PN) has been a relatively uncommon side effect of cisplatin therapy. However, with the administration of high-dose cisplatin (DDP) (40 mg/m2 daily X 5 days), PN symptoms have emerged as a dose-limiting toxicity. Aaronson's et al.
Y, Ostchega, M, Donohue, N, Fox
openaire +2 more sources
Peripheral dose measurement with a MOSFET detector
Applied Radiation and Isotopes, 2005The accuracy of a MOSFET dosimetry system with respect to peripheral therapeutic doses from high-energy X-rays has been evaluated. The results have been compared with ionisation chamber measurements in the same peripheral regions of the beam. For 6 MV and 18 MV X-ray beams, the MOSFET system in the high-sensitivity mode produces reproducibility of dose
Martin J, Butson +2 more
openaire +2 more sources
Dose-Finding Methodology for Peripheral Nerve Blocks
Regional Anesthesia and Pain Medicine, 2014Dose-finding studies enable the successful conduct of peripheral nerve blocks by ensuring the administration of appropriate doses of local anesthetic. However, the optimal dose-finding methodology remains ambiguous. In this research methodology article, we set out to review the basic aspects pertaining to dose-response curves (graded vs quantal), the ...
Theodosios, Saranteas +2 more
openaire +2 more sources
Current concepts regarding drug dosing for peripheral stents
The Journal of Cardiovascular Surgery, 2019Drug-eluting stent (DES) are the mainstay therapy for the treatment of coronary artery disease. Stent design and drug-elution strategies have evolved over the years leading to the last generation DES which shows optimal safety and efficacy outcome. Peripheral arteries have different mechanical and biological features and the lessons learned from the ...
Marco, Ferrone +2 more
openaire +2 more sources
Peripheral Blood Cell Repopulation Following High-Dose Cyclophosphamide
Chemotherapy, 1992High-dose cyclophosphamide can be used to obtain haematological stem cells from the peripheral blood. In this paper we analyse the dynamics of appearance of cells with these characteristics, together with the impact of this drug on the immunological system. Cyclophosphamide seems to possess immunomodulating effects even at high doses.
G, Codacci-Pisanelli +4 more
openaire +2 more sources
High dose etoposide does not cause peripheral neuropathy
Cancer Chemotherapy and Pharmacology, 1987L'etoposide n'est pas un agent neurotoxique et peut etre utilise meme en presence de lesions nerveuses ...
T J, Littlewood +2 more
openaire +2 more sources
Defining a Therapeutic Dose of Peripheral Blood Stem Cells
Journal of Hematotherapy, 1992Peripheral blood stem cells (PBSC) are now used extensively to provide rapid and durable hematopoietic reconstitution following supralethal myeloablative therapies. A major clinical issue is the quantitation of the cells responsible for reconstitution.
J G, Bender +3 more
openaire +2 more sources
High-dose chemotherapy with peripheral blood progenitor autografting
1995Mobilized PBPs are an acceptable alternative to ABMT for hematopoietic rescue following high-dose therapy (table 10-3). Platelet recovery appears to be faster following PBPs than ABMT. In most series, leukocyte recovery is also accelerated, but this may be particularly due to the use of colony-stimulating factor.
J P, Crown, D, Fennelly
openaire +2 more sources
Peripheral Retinopathy and Maculopathy in High-dose Tamoxifen Therapy
American Journal of Ophthalmology, 2007To describe the clinical, angiographic, and optical coherence tomography (OCT) features of high-dose tamoxifen retinopathy in three male patients.Observational case series.A review of history, clinical examination, and findings on fluorescein angiography (FA) and optical coherence tomography (OCT) was conducted.Three male patients receiving high-dose ...
Dan H, Bourla +2 more
openaire +2 more sources
Surface and peripheral doses of dynamic and physical wedges
International Journal of Radiation Oncology*Biology*Physics, 1997The physical and dosimetric differences between three different wedge systems on a multileaf collimator (MLC) equiped linear accelerator are discussed in this report. In particular, the in-field and peripheral surface doses from these wedge systems are measured and their clinical differences discussed.A parallel-plate chamber was used in a solid water ...
Z, Li, E E, Klein
openaire +2 more sources